|
1
|
Vincenti V, Cassano C, Rocchi M and
Persico G: Assignment of the vascular endothelial growth factor
gene to human chromosome 6p21.3. Circulation. 93:1493–1495. 1996.
View Article : Google Scholar
|
|
2
|
Tischer E, Mitchell R, Hartman T, et al:
The human gene for vascular endothelial growth factor. Multiple
protein forms are encoded through alternative exon splicing. J Biol
Chem. 266:11947–11954. 1991.PubMed/NCBI
|
|
3
|
Sa-Nguanraksa D and O-Charoenrat P: The
role of vascular endothelial growth factor A polymorphisms in
breast cancer. Int J Mol Sci. 13:14845–14864. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watson CJ, Webb NJ, Bottomley MJ and
Brenchley PE: Identification of polymorphisms within the vascular
endothelial growth factor (VEGF) gene: correlation with variation
in VEGF protein production. Cytokine. 12:1232–1235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oliveira C, Lourenço GJ, Silva PM, et al:
Polymorphisms in the 5′- and 3′-untranslated region of the VEGF
gene and sporadic breast cancer risk and clinicopathologic
characteristics. Tumour Biol. 32:295–300. 2011.
|
|
6
|
Jin Q, Hemminki K, Enquist K, et al:
Vascular endothelial growth factor polymorphisms in relation to
breast cancer development and prognosis. Clin Cancer Res.
11:3647–3653. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balasubramanian SP, Cox A, Cross SS,
Higham SE, Brown NJ and Reed MW: Influence of VEGF-A gene variation
and protein levels in breast cancer susceptibility and severity.
Int J Cancer. 121:1009–1016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schneider BP, Wang M, Radovich M, et al:
Association of vascular endothelial growth factor and vascular
endothelial growth factor receptor-2 genetic polymorphisms with
outcome in a trial of paclitaxel compared with paclitaxel plus
bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol.
26:4672–4678. 2008. View Article : Google Scholar
|
|
9
|
Lu H, Shu XO, Cui Y, et al: Association of
genetic polymorphisms in the VEGF gene with breast cancer survival.
Cancer Res. 65:5015–5019. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stevens A, Soden J, Brenchley PE, Ralph S
and Ray DW: Haplotype analysis of the polymorphic human vascular
endothelial growth factor gene promoter. Cancer Res. 63:812–816.
2003.PubMed/NCBI
|
|
11
|
O-charoenrat P, Rhys-Evans P, Modjtahedi H
and Eccles SA: Vascular endothelial growth factor family members
are differentially regulated by c-erbB signaling in head and neck
squamous carcinoma cells. Clin Exp Metastasis. 18:155–161. 2000.
View Article : Google Scholar
|
|
12
|
Sa-Nguanraksa D, Chuangsuwanich T,
Pongpruttipan T, et al: Vascular endothelial growth factor −634G/C
polymorphism is associated with increased breast cancer risk and
aggressiveness. Mol Med Rep. 8:1242–1250. 2013.
|
|
13
|
Kostopoulos I, Arapantoni-Dadioti P, Gogas
H, et al: Evaluation of the prognostic value of HER-2 and VEGF in
breast cancer patients participating in a randomized study with
dose-dense sequential adjuvant chemotherapy. Breast Cancer Res
Treat. 96:251–261. 2006. View Article : Google Scholar
|
|
14
|
Ludovini V, Sidoni A, Pistola L, et al:
Evaluation of the prognostic role of vascular endothelial growth
factor and microvessel density in stages I and II breast cancer
patients. Breast Cancer Res Treat. 81:159–168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
MacConmara M, O’Hanlon DM, Kiely MJ,
Connolly Y, Jeffers M and Keane FB: An evaluation of the prognostic
significance of vascular endothelial growth factor in node positive
primary breast carcinoma. Int J Oncol. 20:717–721. 2002.PubMed/NCBI
|
|
16
|
Maae E, Nielsen M, Steffensen KD, Jakobsen
EH, Jakobsen A and Sørensen FB: Estimation of immunohistochemical
expression of VEGF in ductal carcinomas of the breast. J Histochem
Cytochem. 59:750–760. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miller KD, Chap LI, Holmes FA, et al:
Randomized phase III trial of capecitabine compared with
bevacizumab plus capecitabine in patients with previously treated
metastatic breast cancer. J Clin Oncol. 23:792–799. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miller K, Wang M, Gralow J, et al:
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic
breast cancer. N Engl J Med. 357:2666–2676. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Robert NJ, Diéras V, Glaspy J, et al:
RIBBON-1: randomized, double-blind, placebo-controlled, phase III
trial of chemotherapy with or without bevacizumab for first-line
treatment of human epidermal growth factor receptor 2-negative,
locally recurrent or metastatic breast cancer. J Clin Oncol.
29:1252–1260. 2011. View Article : Google Scholar
|
|
20
|
O’Shaughnessy JA and Brufsky AM: RiBBON 1
and RiBBON 2: phase III trials of bevacizumab with standard
chemotherapy for metastatic breast cancer. Clin Breast Cancer.
8:370–373. 2008.PubMed/NCBI
|
|
21
|
Pagès G and Pouysségur J: Transcriptional
regulation of the Vascular Endothelial Growth Factor gene - a
concert of activating factors. Cardiovasc Res. 65:564–573.
2005.PubMed/NCBI
|
|
22
|
Awata T, Inoue K, Kurihara S, et al: A
common polymorphism in the 5′-untranslated region of the VEGF gene
is associated with diabetic retinopathy in type 2 diabetes.
Diabetes. 51:1635–1639. 2002.
|
|
23
|
Morris JF, Hromas R and Rauscher FJ III:
Characterization of the DNA-binding properties of the myeloid zinc
finger protein MZF1: two independent DNA-binding domains recognize
two DNA consensus sequences with a common G-rich core. Mol Cell
Biol. 14:1786–1795. 1994.PubMed/NCBI
|
|
24
|
Awata T, Kurihara S, Takata N, et al:
Functional VEGF C-634G polymorphism is associated with development
of diabetic macular edema and correlated with macular retinal
thickness in type 2 diabetes. Biochem Biophys Res Commun.
333:679–685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huez I, Bornes S, Bresson D, Créancier L
and Prats H: New vascular endothelial growth factor isoform
generated by internal ribosome entry site-driven CUG translation
initiation. Mol Endocrinol. 15:2197–2210. 2001. View Article : Google Scholar : PubMed/NCBI
|
